Editor - Neuro-Oncology Advances
@EditorNeuro
Followers
2K
Following
3K
Media
451
Statuses
735
Dr. Gelareh Zadeh - Editor-in-Chief of the Neuro-Oncology Advances Journal https://t.co/DIZeqLXgdx @gelarehzadeh
Joined February 2022
We welcome working with you on manuscripts in any area of #braintumor #CancerResearch #cancercare #spinetumors #metastases #pediatricbraintumor #molecularpathology #Neurosurgery #neuroscience of #braincancer & more. neuro.onc.advances@gmail.com.
academic.oup.com
Neuro-Oncology Advances is an Open Access journal covering basic, applied, and clinical investigations in all areas as they relate to cancer and the central nervous system. NOA welcomes direct...
5
20
113
Read “Advancing #vaccine-based #immunotherapy in #glioblastoma treatment” in our latest issue. Authors: Desh Deepak Singh, Shafiul Haque, Abhishek Kumar Singh, Dharmendra Kumar Yadav.
0
0
6
RT @NeuroOnc: Just launched: Neuro-Oncology Pediatrics!. A new open-access journal dedicated to advancing care & research for children and….
0
15
0
This review details the indications, risks, and outcomes of #PituitaryRadiosurgery and radiation therapy, and presents in brief the differences in treatment approaches between stereotactic radiosurgery, fractionated radiation therapy, and proton therapy.
0
5
13
This new article reviews wide-ranging conditions that can mimic primary #PituitaryTumors and outlines a suggested approach to rational decision-making. Read now:
0
4
12
Read the new article ‘Nuances in #VisualRehabilitation after pituitary surgery’ by @SakshamGuptaMD and @wenyalindabi in our latest supplement on #PituitaryTumors:.
0
5
18
Read “Beyond the #sella: Expanded #endoscopic #endonasal approaches for pituitary tumors” in our new supplement on #PituitaryTumors now:.
0
4
14
Read ‘Current understanding of the role of #DNA methylation in #pituitary #neuroendocrine tumors’ in our new supplement on #PituitaryTumors:. @DoctorZada
0
3
19
Have you read our new supplement on #PituitaryTumors yet? . Here are the great articles you can find in the new issue! .
0
4
16
What are your peers reading? . Here are the top three most read #articles from last month in #NeuroOncology Advances!.
0
1
9
RT @LabWaggoner: Dual immunotherapeutic interventions with FDA-approved antibodies Tiragolumab (anti-TIGIT) & Durvalumab (anti-PD-1) potent….
0
6
0
Welcoming publications on perspectives on AI in NeuroOncology and Brain Tumors.
Policy Corner by Abdullah H. Ishaque, MD, PhD (@ahishaque), @AbdiAidid, JD, LLM, and @gelarehzadeh, MD, PhD: Lessons from the Failure of Canada’s Artificial Intelligence and Data Act . #AIinMedicine
0
1
4
RT @gelarehzadeh: I hope to make a difference if I can to patients journey when diagnosed with #braintumors #meningiomas #pituitarytumors #….
instagram.com
0
3
0
RT @MayoClinicNeuro: Mayo Clinic’s latest course in Rochester, MN, “Open and Endoscopic Techniques to the Cranial Base Surgery Course” Led….
0
15
0
What is the utility of arterial spin labeling perfusion MRI (#ASLMRI) for accurately differentiating between #RadiationNecrosis and tumor in #BrainMetastases treated with #StereotacticRadiosurgery? . Read the article in our latest issue:
1
1
6
At #NeuroOncology Advances, we are proud to be an open access journal. @OxUniPress aims to achieve the widest possible dissemination of high-quality research, upholding the highest standards of publication ethics & integrity. Learn more about #OpenAccess:
0
0
2
Findings:.- Distant progression is associated with poor prognosis.- Unmethylated MGMT, multicentric disease, and NF1 alteration predict distant progression.- NF1 alteration is a prognostic factor and may serve as a predictive factor for targeted treat.
0
1
8
Read “PNOC009: Convection-enhanced delivery of liposomal irinotecan in patients with newly diagnosed diffuse intrinsic pontine #glioma” in our latest issue:
0
1
4